Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists

Recruiting N/A Interventional Study
Chronic Pain
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
664 (estimated)
Sponsor
Centre Hospitalier Emile Roux · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * First consultation at the pain management center * Patient with chronic pain as defined by the "Haute Autorité de Santé". The pain must have several of the following characteristics: * Persistence or recurrence * Duration beyond what is usual for the presumed initial caus…
Contacts

No contact information available.